Fig. (5) Endothelial dysfunction is a bridge between T2DM and cardiovascular diseases. Increased levels of FFA and DAG trigger a serine/threonine kinase cascade, ultimately inducing serine/threonine phosphorylation of critical IRS-1 sites and thereby inhibiting IRS-1 binding and the activation of PI3-kinase, which results in reduced insulin-stimulated glucose transport.